Iuventis Technologies, Inc.
Technology development company conducting R&D across biotechnology, pharmaceuticals, cybersecurity, advanced agriculture, and renewable energy. Operates project groups developing polymer nanoparticle delivery systems, peptide therapeutic programs, RNAi delivery methods using viral/phage vectors, elliptic-curve cryptography for biomedical data protection, and photobiological hydrogen/biofuel production technologies.
Industries
N/A
Products
Water-based PEG polymer nanoparticle delivery system
A water-based PEG copolymer nanoparticle system (reported 50–80 nm) intended to carry various molecular cargos; described as biologically inactive and produced via chemo-enzymatic methods.
Peptide therapeutic development program
Discovery and development program for naturally occurring peptides targeting infectious diseases and CNS disorders, with activities aimed at clinical development and regulatory submission.
RNAi delivery platform using viral/phage capsules
A delivery approach employing viral/phage capsules carrying hairpin RNAi oligomers with targeting arms to direct RNAi activity toward cancer cells.
Cryptographic data-security platform for biomedical data
Elliptic-curve-based cryptographic tools designed for biomedical research data protection, enabling operations on encrypted records, dynamic masking, tokenization, and analytics while preserving privacy.
Solid-phase photobiological hydrogen and biofuel production technology
A solid-phase, high-yield photobiological process for hydrogen and biofuel component production, with reported increased yields versus conventional methods and ongoing scale-up efforts.
Water-based PEG polymer nanoparticle delivery system
A water-based PEG copolymer nanoparticle system (reported 50–80 nm) intended to carry various molecular cargos; described as biologically inactive and produced via chemo-enzymatic methods.
Peptide therapeutic development program
Discovery and development program for naturally occurring peptides targeting infectious diseases and CNS disorders, with activities aimed at clinical development and regulatory submission.
RNAi delivery platform using viral/phage capsules
A delivery approach employing viral/phage capsules carrying hairpin RNAi oligomers with targeting arms to direct RNAi activity toward cancer cells.
Cryptographic data-security platform for biomedical data
Elliptic-curve-based cryptographic tools designed for biomedical research data protection, enabling operations on encrypted records, dynamic masking, tokenization, and analytics while preserving privacy.
Solid-phase photobiological hydrogen and biofuel production technology
A solid-phase, high-yield photobiological process for hydrogen and biofuel component production, with reported increased yields versus conventional methods and ongoing scale-up efforts.
Services
Technology collaboration and licensing
Collaborative research, licensing, and partnership engagements for development or commercialization of technologies.
Technology collaboration and licensing
Collaborative research, licensing, and partnership engagements for development or commercialization of technologies.
Expertise Areas
- Nanoparticle drug delivery
- Therapeutic peptide development
- RNA interference delivery systems
- Bioprocess scale-up for biofuels
Key Technologies
- PEG-based polymer nanoparticles
- Chemo-enzymatic nanoparticle synthesis
- RNA interference (RNAi) delivery
- Viral/phage-based targeting vectors